Renal haemodynamic characteristics in patients with lupus nephritis

Annals of the Rheumatic Diseases

Volumn 57, Issue 4, 1998, Pages 226-230

  Nakano, Masaaki ^a   Ueno, Mitsuhiro ^a   Hasegawa, Hisashi ^a   Watanabe, Takeshi ^a   Kuroda, Takeshi ^a   Ito, Satoshi ^a   Arakawa, Masaaki ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY BLOOD FLOW; KIDNEY PLASMA FLOW; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; PREDICTION; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0031878630     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.57.4.226     Document Type: Article

References (34)

1. Laitman RS, Glicklich D, Sablay LB, Grayzel AI, Barland P, Bank N. Effect of long-term normalization of serum complement levels on the course of lupus nephritis. Am J Med 1989;87:132-8.
2. Smeenk R, Brinkman K, van den Brink H, Termaat RM, Berden J, Nossent H, et al. Antibody to DMA in patients with systemic lupus erythematosus. Their role in the diagnosis, the follow-up and the pathogenesis of the disease. Clin Rheumatol 1990;9 (suppl 1):100-10.
3. Esdaile JM, Abrahamowicz M, MacKenzie T, Hayslett JP, Kashgarian M. The time dependence of long-term prediction in lupus nephritis. Arthritis Rheum 1994;37:359-68.
4. Rosner S, Ginzler EM, Diamond HS, Weiner M, Schlesinger M, Fries JF, et al. A multicenter study of outcome in systemic lupus erythematosus. II Causes of death. Arthritis Rheum 1982;25:612-17.
5. Derksen RH, Hene RJ, Kater L. The long-term clinical outcome of 56 patients with biopsy-proven lupus nephritis followed at a single center. Lupus 1992;1:97-103.
6. Gruppo Itariano per lo Studio della Nefrite Lupica (GISNEL). Lupus nephritis: prognostic factors and probability of maintaining life-supporting renal function 10 years after the diagnosis. Am J Kidney Dis 1992;19:473-9.
7. Appel GB, Cohen DJ, Pirani CL, Meltzer JI, Estes D. Long-term follow-up of patients with lupus nephritis. A study based on the classification of the World Health Organization. Am J Med 1987;83:877-85.
8. Nossent HC, Henzen-Logmans SC, Vroom TM, Berden JH, Swaak T J. Contribution of renal biopsy data in predicting outcome in lupus nephritis: analysis of 116 patients. Arthritis Rheum 1990;33:970-7.
9. Schwartz MM, Lan SP, Bonsib SM, Gephardt GN, Sharma HM. Clinical outcome of three discrete histologic patterns of injury in severe lupus glomerulonephritis. Am J Kidney Dis 1989;13:273-83.
10. Magil AB, Puterman ML, Ballon HS, Chan V, Lirenman DS, Rae A, Sutton RAL. Prognostic factors in diffuse proliferative lupus glomerulonephritis. Kidney Int 1988;34: 511-17.
11. Austin HA III, Muenz LR, Joyce KM, Antonovych TA, Kullich ME, Klippel JH, et al. Prognostic factors in lupus nephritis. Contribution of renal histologic data. Am J Med 1983;75:382-91.
12. Favre H, Miescher PA. Filtration fraction: an index of renal disease activity in patients with systemic lupus erythematosus. Proceedings of the European Dialysis and Transplant Association 1984;21:717-21.
13. Kallenberg CGM, Schweitzer C, de Jong PE, Donker AJMM, van der Hem GK. Decreased nitration fraction during active proliferative lupus nephritis: relation to disease activity and reversibility of renal function. Clin Nephrol 1984;22:223-9.
14. Rosenbaum JL, Akhtar M, Kramer MS, Raja RM, Manchanda R, Lazaro N. Evaluation of clearance studies in lupus nephritis. Clin Nephrol 1974;2:47-51.
15. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
16. Brun C. Thiosulphate determination in kidney function tests - a simple model for the determination of thiosulphate in blood and urine. J Lab Clin Med 1950;35:152-4.
17. Saito T, Nishi S, Karasawa R, In H, Hayashi H, Ueno M, et al. An ultrastructural study of glomerular basement membrane in rheumatoid arthritis patients with urinary abnormalities. Clin Nephrol 1995;43:360-7.
18. Ter Borg EJ, de Jong PE, Meijer S, Kallenberg CGMM. Renal effects of indomethacin in patients with systemic lupus erythematosus. Nephron 1989;53:238-43.
19. Nakano M, Ueno M, Nishi S, Suzuki S, Hasegawa H, Watanabe T, et al. Determination of IgA- and IgM-rheumatoid factors in patients with rheumatoid arthritis with and without nephropathy. Ann Rheum Dis 1996;55: 520-4.
20. Churg J, Bernstein J, Glassock RJ. Lupus nephritis. In: Churg J, Bernstein J, Glassock RJ, eds. Renal disease: classification and atlas of glomerular disease. 2nd ed. New York: Igaku-shoin Medical, 1995: 151-6.
21. Parrish AE, Kramer NC, Hatch FE, Watt MMF, Home JS. The relation between glomerular function and histology in acute glomerulonephritis. J Lab Clin Med 1961;58:197-203.
22. Lowenstein J, Schacht RG, Baldwin DS. Renal failure in minimal change nephrotic syndrome. Am J Med 1981;70: 227-33.
23. Rahman MA, Emancipator SN, Dunn MJ. Immune complex effects on glomerular eicosanoid production and renal hemodynamics. Kidney Int 1987;31:1317-26.
24. Kimberly RP, Plotz PH. Aspirin-induced depression of renal function. N Engl J Med 1977;296:418-24.
25. Kimberly RP, Gill JR, Bowden RK, Keiser HR, Plotz PH. Elevated urinary prostaglandins and the effects of aspirin on renal function in lupus erythematosus. Ann Intern Med 1978;89:336-41.
26. Patrono G, Ciabattoni G, Remuzzi G, Gotti E, Bombardieri S, Munno OD, et al. Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus. J Clin Invest 1985;76:1011-18.
27. Yoshida T, Ichikawa Y, Tojo T, Homma M. Abnormal prostanoid metabolism in lupus nephritis and the effects of a thromboxane A2 synthetase inhibitor, DP-1904. Lupus 1996;5:129-38.
28. Steinhausen M, Endlich K. Glomerular blood flow. Kidney Int 1990;38:769-84.
29. Marre M, Chatellier G, Leblanc H, Guyene TT, Menard J, Passa P. Prevention of diabetic nephropathy with enalapril in normotensive diabetics with micro albuminuria. BMJ 1988;297:1092-5.
30. Björck S, Nyberg G, Mulec H, Granerus G, Herlitz H, Aurell M. Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. BMJ 1986;293:471-4.
31. Stein JH. Regulation of the renal circulation. Kidney Int 1990;38:571-6.
32. Petri M, Bockenstedt L, Colman J, Whiting-O'Keefe Q, Fitz G, Sebastian A, et al. Serial assessment of glomerular filtration rate in lupus nephropathy. Kidney Int 1988;34: 832-9.
33. Bauer JH, Brooks CS, Burch RN. Clinical appraisal of creatinine clearance as a measurement of glomerular filtration rate. Am J Kidney Dis 1982;22:337-40.
34. Sugita O, Tomiyama Y, Matsuto T, Okada M, Gejyo F, Arakawa M, et al. A new enzymatic method for the determination of inulin. Ann Clin Biochem 1995;32: 561-5.